Atlas Trials

Inhaled Ciclesonide for Outpatients With COVID19

Clinical trial NCT04435795 · TERMINATED

Trial details

NCT number
NCT04435795
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID 19
Start date
2020-09-15
Primary completion
2021-06-08
Enrollment
215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.